13F Holdings
中文EN

DRIO DarioHealth Corp.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1533998 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-13.9%
TTM net income YoY19.5%
TTM EPS YoY-67.7%
Revenue 3-yr CAGR-3.3%
Net income 3-yr CAGR—

Margins

Gross margin57.9%
Operating margin-142.7%
Net margin-159.9%
FCF margin-111.0%
EBITDA margin-141.7%

Returns

ROE-46.6%
ROA-29.6%
ROIC (approx.)-32.4%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets36.6%
Debt / equity0.44x
Current ratio4.20x
Interest coverage-6.81x

Cash quality & payout

Operating cash flow / net income0.69x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$22.36M$27.04M$20.35M$27.66M$20.51M
Cost of revenue$9.69M$13.77M$14.37M$18.00M$16.55M
Gross profit$12.66M$13.27M$5.98M$9.65M$3.96M
R&D expense$13.79M$24.18M$20.25M$19.65M$17.22M
SG&A expense$15.19M$20.48M$18.14M$16.49M$23.53M
Operating income-$36.66M-$57.74M-$56.19M-$56.81M-$76.49M
Interest expense$3.02M——$1.88M—
Pretax income-$41.61M-$44.60M-$59.36M-$62.19M-$76.73M
Income tax$105,000-$1.85M$64,000$4,000$32,000
Net income-$41.71M-$42.75M-$59.43M-$62.19M-$76.76M
EBITDA-$36.35M-$56.42M-$55.72M-$56.45M-$76.21M
EPS (basic)10.1212.271.932.544.07
EPS (diluted)10.1212.271.932.544.07
Weighted avg. shares (diluted)3.98M2.45M28.37M23.64M16.59M
Balance sheet
Cash & equivalents$21.80M$27.76M$36.80M$49.47M$35.95M
Short-term investments$4.21M————
Inventory$4.32M$4.75M$5.06M$7.96M$6.23M
Current assets$35.07M$40.53M$47.33M$65.52M$45.60M
PP&E, net$549,000$709,000$899,000$788,000$702,000
Goodwill$57.43M$57.43M$41.64M$41.64M$41.64M
Intangibles$15.93M$18.76M$5.40M$9.92M$12.46M
Total assets$110.08M$118.88M$96.39M$119.19M$100.77M
Current liabilities$9.32M$16.64M$12.49M$19.35M$14.38M
Short-term debt—$5.45M$3.95M$8.82M$0
Long-term debt$30.75M$23.47M$24.59M$18.11M$0
Total debt$30.75M$28.92M$28.55M$26.93M$0
Total liabilities$42.15M$46.87M$38.24M$39.19M$15.22M
Shareholders' equity$67.92M$72.02M$58.14M$80.00M$85.55M
Net debt$8.94M$1.16M-$8.25M-$22.54M-$35.95M
Shares outstanding6.91M1.92M27.19M25.72M16.57M
Cash flow statement
Operating cash flow-$25.94M-$38.56M-$30.38M-$47.84M-$50.41M
Capital expenditure$142,000$138,000$584,000$442,000$261,000
Free cash flow-$26.08M-$38.70M-$30.96M-$48.29M-$50.67M
Investing cash flow-$4.34M-$8.93M-$547,000-$573,000-$8.13M
Financing cash flow$24.31M$38.53M$18.25M$61.94M$65.77M
Depreciation & amortization$307,000$1.33M$473,000$356,000$282,000
Stock-based compensation$9.37M$46,000$19.70M$16.98M$24.97M
Share buybacks———$134,000—

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.